AI Article Synopsis

  • Melanoacanthoma is a rare, benign tumor that involves both keratinocytes and melanocytes, distinguishing it from the related condition seborrheic keratosis.
  • * It features large melanocytes filled with melanin and shows issues in transferring melanin to surrounding skin cells.
  • * The study introduces a unique staining method (VECTOR® NovaRED™) that helps differentiate between melanocytes and melanin-laden keratinocytes for better diagnosis.*

Article Abstract

Melanoacanthoma is a rare benign mixed tumor of both keratinocytes and melanocytes. Although some authors said that it is a rare variant of seborrheic keratosis, it has clinical and histological features distinct from seborrheic keratosis. It has large dendritic melanin-laden melanocytes throughout all levels of epidermis showing a disruption of melanin transfer from the melanocytes to neighboring keratinocytes. However, it is difficult to distinguish melanocytes clearly from cutaneous pigment in immunohistochemical stain with usually used brown chromogen. We used chromogen with brick-red indicator product (VECTOR® NovaRED™) in S-100 and melan-A immunohistochemical staining to distinguish melanocytes from melanin laden keratinocytes. We suggest that the immunohistochemical staining using this novel chromogen may be useful in the diagnosis of melanoacanthoma.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4904042PMC
http://dx.doi.org/10.5021/ad.2008.20.1.18DOI Listing

Publication Analysis

Top Keywords

immunohistochemical staining
12
distinguish melanocytes
12
vector® novared™
8
cutaneous pigment
8
seborrheic keratosis
8
melanocytes
6
case melanoacanthoma
4
immunohistochemical
4
melanoacanthoma immunohistochemical
4
staining vector®
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!